Sequential Injection Analysis of Cholesterol Using an Oxidation–Reduction Electrode Detector
Sensors · 2025
DOI: 10.3390/s25185863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2025. Verfasst von Takato Imanaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Shibaura Institute of Technology, Koto-ku, Tokyo 135-8548, Japan. Hauptthemen laut MEDLINE: Cholesterol, Biosensing Techniques, Flow Injection Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A new automated method for the determination of cholesterol in serum was developed by combining sequential injection analysis (SIA) with potentiometric detection using a gold oxidation–reduction potential (ORP) electrode because serum cholesterol is an important indicator of abnormal lipid metabolism, arteriosclerosis, and hypertension in clinical diagnosis. The method is based on enzymatic hydrolysis of cholesterol esters by cholesterol esterase (CE) to yield free cholesterol, followed by oxidation with cholesterol oxidase (COD) to produce hydrogen peroxide. In the presence of horseradish peroxidase (HRP) and potassium ferrocyanide (K4[Fe(CN)6]), hydrogen peroxide oxidizes ferrocyanide to ferricyanide (K3[Fe(CN)6]), and the concentration ratio of ferri-/ferrocyanide is determined potentiometrically. Experimental conditions were optimized as follows: 5.0 mM K4[Fe(CN)6], 2 min reaction time, 0.5 units/mL HRP, 0.75 units/mL COD for free cholesterol, 1.5 units/mL COD and 10.0 units/mL CE for total cholesterol, and 5.0% (w/v) Triton X-100 with 5.0% (v/v) isopropanol as solubilizing agents. Under these conditions, the calibration curve for total cholesterol exhibited a Nernstian slope of 47.6 mV/decade over the range of 1.0 × 10−5–1.0 × 10−3 M, with no significant interference from common serum constituents. This method offers low reagent consumption, high automation, and simple operation, making it promising for clinical cholesterol analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, Shibaura Institute of Technology, Koto-ku, Tokyo 135-8548, Japan.
ORCID-Profile: Takashi Masadome
Zitieren
APA
Imanaka, T., & Masadome, T. (2025). Sequential Injection Analysis of Cholesterol Using an Oxidation–Reduction Electrode Detector. Sensors. https://doi.org/10.3390/s25185863
Vancouver
Imanaka T, Masadome T. Sequential Injection Analysis of Cholesterol Using an Oxidation–Reduction Electrode Detector. Sensors. 2025. doi:10.3390/s25185863
BibTeX
@article{Imanaka2025,
author = {Imanaka, Takato and Masadome, Takashi},
title = {Sequential Injection Analysis of Cholesterol Using an Oxidation–Reduction Electrode Detector},
journal = {Sensors},
year = {2025},
doi = {10.3390/s25185863}
}
EUVIMED